Profil
Yasutoshi Kawakami is currently the Chairman at NeuroDerm Ltd., the Vice President and Head of US & Europe Business at Mitsubishi Tanabe Pharma Corp., and the President at Mitsubishi Tanabe Pharma America, Inc. He previously served as the President at Mitsubishi Tanabe Pharma Holdings America, Inc.
Postes actifs de Yasutoshi Kawakami
| Sociétés | Poste | Début |
|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | 19/06/2020 |
| NEURODERM LTD | Président | 01/04/2020 |
Mitsubishi Tanabe Pharma America, Inc.
 Mitsubishi Tanabe Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a pharmaceutical company based in Jersey City, NJ. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) and was established to develop and advance their pipeline as well as commercialize approved pharmaceutical products in the United States. MTPA delivers innovative solutions that are guided by patients' unmet medical needs. | President | 03/04/2023 |
Anciens postes connus de Yasutoshi Kawakami
| Sociétés | Poste | Fin |
|---|---|---|
Mitsubishi Tanabe Pharma Holdings America, Inc.
 Mitsubishi Tanabe Pharma Holdings America, Inc. Pharmaceuticals: OtherHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Holdings America, Inc. manufactures and distributes pharmaceuticals, pet products & medicines. The private company is based in Jersey City, NJ. | President | 03/04/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
Mitsubishi Tanabe Pharma Holdings America, Inc.
Mitsubishi Tanabe Pharma Holdings America, Inc. Pharmaceuticals: OtherHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Holdings America, Inc. manufactures and distributes pharmaceuticals, pet products & medicines. The private company is based in Jersey City, NJ. | Health Technology |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Mitsubishi Tanabe Pharma America, Inc.
Mitsubishi Tanabe Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a pharmaceutical company based in Jersey City, NJ. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) and was established to develop and advance their pipeline as well as commercialize approved pharmaceutical products in the United States. MTPA delivers innovative solutions that are guided by patients' unmet medical needs. | Health Technology |
